Fragile mental retardation protein interacts with the RNA-binding protein Caprin1 in neuronal ribonucleoprotein complexes

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  El Fatimy, Rachid ^a,b   Tremblay, Sandra ^a   Dury, Alain Y ^a,b   Solomon, Samuel ^c   de Koninck, Paul ^a,b   Schrader, John W ^c   Khandjian, Edouard W ^a,b  

^a CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN CAMKIIALPHA; PROTEIN CAPRIN1; PROTEIN MAP1B; RIBONUCLEOPROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL GRANULE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL; NEWBORN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN TARGETING; PROTEIN TRANSPORT; RAT; TRANSLATION REGULATION;

AMINO ACID MOTIFS; ANIMALS; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; BRAIN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL CYCLE PROTEINS; DNA PRIMERS; FRAGILE X MENTAL RETARDATION PROTEIN; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; NEURONS; NIH 3T3 CELLS; POLYRIBOSOMES; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; RIBONUCLEOPROTEINS; RNA-BINDING PROTEINS;

EID: 84862667070     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039338     Document Type: Article

References (60)

1. O'Donnell WT, Warren ST, (2002) A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci 25: 315-338.
2. Bardoni B, Davidovic L, Bensaid M, Khandjian EW, (2006) The fragile X syndrome: exploring its molecular basis and seeking a treatment. Expert Rev Mol Med 8: 1-16.
3. Bassell GJ, Warren ST, (2008) Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function. Neuron 60: 201-214.
4. Khandjian EW, Fortin A, Thibodeau A, Tremblay S, Cote F, et al. (1995) A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture. Hum Mol Genet 4: 783-789.
5. Devys D, Lutz Y, Rouyer N, Bellocq J-P, Mandel J-L, (1993) The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nature Genet 4: 335-340.
6. Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST, et al. (1997) Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 17: 1539-1547.
7. Khandjian EW, Huot ME, Tremblay S, Davidovic L, Mazroui R, et al. (2004) Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles. Proc Natl Acad Sci USA 101: 13357-13362.
8. Stefani G, Fraser CE, Darnell JC, Darnell RB, (2004) Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. J Neurosci 24: 7272-7276.
9. Khandjian EW, Tournier B, Séguin S, Tremblay S, De Koninck P, et al. (2009) RNA Granules: Functions within Presynaptic Terminals and Postsynaptic Spines. In: Squire LR, editors. Encyclopedia of Neuroscience, volume 8, pp 389-395. Academic Press. Oxford.
10. Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazelton AD, et al. (1997) Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci USA 94: 5395-5400.
11. Kao D-I, Aldridge GM, Weiler IJ, Greenough WT, (2010) Altered mRNA transport, docking, and protein translation in neurons lacking fragile X mental retardation protein. Proc Natl Acad Sci USA 107: 15601-15606.
12. Darnell J, (2011) Defects in translational regulation contributing to human cognitive and behavioral disease. Curr Opin Genet Dev 21: 465-473.
13. Hinton VJ, Brown WT, Wisniewski K, Rudelli RD, (1991) Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet 41: 289-294.
14. Grossman AW, Aldridge GM, Weiler IJ, Greenough WT, (2006) Local Protein Synthesis and Spine Morphogenesis: Fragile X Syndrome and Beyond. J Neurosc 26: 7151-7155.
15. Brown V, Jin P, Ceman S, Darnell JC, O'Donnell WT, et al. (2001) Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107: 477-487.
16. Miyashiro KY, Beckel-Mitchener A, Purk TP, Becker KG, Barret T, et al. (2003) RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37: 417-431.
17. Sung YJ, Conti J, Currie JR, Brown WT, Denman RB, (2000) RNAs that interact with the fragile X syndrome RNA binding protein FMRP. Biochem Biophys Res Commun 275: 973-980.
18. Chen L, Yun S-W, Seto J, Liu W, Toth M, (2003) The Fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U-rich target sequences. Neuroscience 120: 1005-1017.
19. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, et al. (2011) FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism. Cell 146: 247-261.
20. Khandjian EW, Bechara E, Davidovic L, Bardoni B, (2005) Fragile X Mental Retardation Protein: Many Partners and Multiple Targets for a Promiscuous Function. Current Genomics 6: 523-531.
21. Mazroui R, Huot ME, Tremblay S, Boilard N, Labelle Y, et al. (2003) Fragile X Mental Retardation Protein determinants required for its association with polyribosomal mRNPs. Hum Mol Genet 12: 3087-3096.
22. Davidovic L, Bechara E, Gravel M, Jaglin XH, Tremblay S, et al. (2006) The nuclear microspherule protein 58 is a novel RNA-binding protein that interacts with fragile X mental retardation protein in polyribosomal mRNPs from neurons. Hum Mol Genet 15: 1525-1538.
23. Davidovic L, Jaglin XH, Lepagnol-Bestel AM, Tremblay S, Simonneau M, et al. (2007) The fragile X mental retardation protein is a molecular adaptor between the neurospecific KIF3C kinesin and dendritic RNA granules. Hum Mol Genet 16: 3047-3058.
24. Menon RP, Gibson TJ, Pastore A, (2004) The C terminus of fragile X mental retardation protein interacts with the multi-domain Ran binding protein in the microtubule-organising centre. J Mol Biol 343: 43-53.
25. Piazzon N, Rage F, Schlotter F, Moine H, Branlant C, et al. (2008) In vitro and in cellulo evidences for association of the survival of motor neuron complex with the Fragile X Mental Retardation protein. J Biol Chem 283: 5598-5610.
26. Ceman S, Brown V, Warren ST, (1999) Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Mol Cell Biol 19: 7925-7932.
27. Ceman S, Nelson R, Warren ST, (2000) Identification of mouse YB1/p50 as a component of the FMRP-associated mRNP particle. Biochem Biophys Res Commun 279: 904-908.
28. Ohashi S, Koike K, Omori A, Ichinose S, Ohara S, et al. (2002) Identification of mRNA/protein (mRNP) complexes containing Pur-alpha, mStaufen, fragile X protein, and myosin Va and their association with rough endoplasmic reticulum equipped with a kinesin motor. J Biol Chem 277: 37804-37810.
29. Shiina N, Tokunaga M, (2010) RNA granule protein 140 (RNG140), a paralog of RNG105 localized to distinct RNA granules in neuronal dendrites in the adult vertebrate brain. J Biol Chem 285: 24260-24269.
30. Grill B, Wilson GM, Zhang KX, Wang B, Doyonnas R, et al. (2004) Activation/division of lymphocytes results in increased levels of cytoplasmic activation/proliferation-associated protein-1: prototype of a new family of proteins. J Immunol 172: 2389-2400.
31. Shiina N, Shinkura K, Tokunaga M, (2005) A novel RNA-binding protein in neuronal RNA granules: regulatory machinery for local translation. J Neurosci 25: 4420-4434.
32. Mientjes EJ, Nieuwenhuizen I, Kirkpatrick L, Zu T, Hoogeveen-Westerveld M, et al. (2006) The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo. Neurobiol Dis 21: 549-555.
33. Ceman S, Zhang F, Johnson T, Warren ST, (2003) Development and characterization of antibodies that immunoprecipitate the FMR1 protein. Methods Mol Biol 217: 345-354.
34. Mazroui R, Huot ME, Tremblay S, Filion C, Labelle Y, et al. (2002) Trapping of messenger RNA by Fragile X Mental Retardation protein into cytoplasmic granules induces translation repression. Hum Mol Genet 11: 3007-3017.
35. Costa A, Wang Y, Erdjument-Bromage H, Tempst P, Schedl P, et al. (2005) The Drosophila fragile X protein functions as a negative regulator in the orb autoregulatory pathway. Develop Cell 8: 331-342.
36. Förch P, Puig O, Martinez C, Séraphin B, Valcarcel J, (2002) The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5′ splice sites. EMBO J 21: 6882-6892.
37. Salvetti A, Batistoni R, Deri P, Rossi L, Sommerville J, (1998) Expression of DjY1, a protein containing a cold shock domain and RG repeat motifs, is targeted to sites of regeneration in planarians. Dev Biol 201: 217-229.
38. Chi SW, Zang JB, Mele A, Darnell RB, (2009) Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460: 479-486.
39. Falvey AK, Staehelin T, (1970) Structure and function of mammalian ribosomes. I. Isolation and characterization of active liver ribosomal subunits. J Mol Biol 53: 1-19.
40. Martin TE, Hartwell LH, (1970) Resistance of active yeast ribosomes to dissociation by KCl. J Biol Chem 245: 1504-1506.
41. Zylber EA, Penman S, (1970) The effect of high ionic strength on monomers, polyribosomes, and puromycin-treated polyribosomes. Biochim Biophys Acta 204: 221-229.
42. Hensold JO, Barth-Baus D, Stratton CA, (1996) Inducers of erythroleukemic differentiation cause messenger RNAs that lack poly(A)-binding protein to accumulate in translationally inactive, salt-labile 80S ribosomal complexes. J Biol Chem 271: 23246-23254.
43. Solomon S, Xu Y, Wang B, David MD, Schubert P, et al. (2007) Distinct structural features of caprin-1 mediate its interaction with G3BP-1 and its induction of phosphorylation of eukaryotic translation initiation factor 2alpha, entry to cytoplasmic stress granules, and selective interaction with a subset of mRNAs. Mol Cell Biol 27: 2324-2342.
44. Papoulas O, Monzo KF, Cantin GT, Ruse C, Yates JR 3rd, et al. (2010) dFMRP and Caprin, translational regulators of synaptic plasticity, control the cell cycle at the Drosophila mid-blastula transition. Development 137: 4201-4209.
45. Wang B, David MD, Schrader JW, (2005) Absence of caprin-1 results in defects in cellular proliferation. J Immunol 175: 4274-4282.
46. Sofola O, Sundram V, Ng F, Kleyner Y, Morales J, et al. (2008) The Drosophila FMRP and LARK RNA-binding proteins function together to regulate eye development and circadian behavior. J Neurosci 28: 10200-10205.
47. Laggerbauer B, Ostareck D, Keidel E-M, Ostareck-Lederer A, Fischer U, (2001) Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum Mol Genet 10: 329-338.
48. Li Z, Zhang Y, Ku L, Wilkinson KD, Warren ST, et al. (2001) The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acid Res 29: 2276-2283.
49. Bechara EG, Didiot MC, Melko M, Davidovic L, Bensaid M, et al. (2009) A novel function for fragile X mental retardation protein in translational activation. PLoS Biol 7: e16.
50. Fähling M, Mrowka R, Steege A, Kirschner KM, Benko E, et al. (2009) Translational regulation of the human achaete-scute homologue-1 by fragile X mental retardation protein. J Biol Chem 284: 4255-4266.
51. Davidovic L, Tremblay S, De Koninck P, Khandjian EW, (2005) Fragile X Mental Retardation Protein: To be or not to be a Translational Repressor. In: Sung Y-J, Denman RB, editors. editors. The Molecular Basis of Fragile X Syndrome. pp 129-143. Research Signposts.
52. Kanai Y, Dohmae N, Hirokawa N, (2004) Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 43: 513-525.
53. Ling SC, Fahrner PS, Greenough WT, Gelfand VI, (2004) Transport of Drosophila fragile X mental retardation protein-containing ribonucleoprotein granules by kinesin-1 and cytoplasmic dynein. Proc Natl Acad Sci USA 101: 17428-17433.
54. Eberhart DE, Malter HE, Feng Y, Warren ST, (1996) The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet 5: 1083-1091.
55. Khandjian EW, (1999) Biology of the fragile X mental retardation protein, an RNA-binding protein. Biochem Cell Biol 77: 331-342.
56. Zhang Y, O'Connor JP, Siomi MC, Srinivasan S, Dutra A, et al. (1995) The Fragile X Mental Retardation Syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J 14: 5358-5366.
57. Darnell JC, Mostovetsky O, Darnell RB, (2005) FMRP RNA targets: identification and validation. Genes Brain Behav 4: 341-349.
58. Darnell JC, Fraser CE, Mostovetsky O, Stefani G, Jones TA, et al. (2005) Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev 19: 903-918.
59. Bechara E, Davidovic L, Melko M, Bensaid M, Tremblay S, et al. (2006) Fragile X related protein 1 isoforms differentially modulate the affinity of fragile X mental retardation protein for G-quartet RNA structure. Nucl Acids Res 35: 299-306.
60. Hudmon A, Lebel E, Roy H, Sik A, Schulman H, et al. (2005) A mechanism for Ca2+/calmodulin-dependent protein kinase II clustering at synaptic and nonsynaptic sites based on self-association. J Neurosci 25: 6971-6983.